Barclays
BTAL icon

Barclays’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Barclays’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.6K Buy
+1,797
New +$21.6K ﹤0.01% 4731

Other funds holding BTAL

Carrera Capital Advisors
Carrera Capital Advisors Troy, Michigan $705M AUM 12.86% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
Crescent Grove Advisors
Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
CFA
Collaborative Fund Advisors Reno, Nevada $186M AUM
Good Steward Wealth Advisors
Good Steward Wealth Advisors Clarksville, Tennessee $167M AUM 10.63% 1-Year Est. Return
Avestar Capital
Avestar Capital New York $1.27B AUM 25.49% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
LA
Latitude Advisors Vero Beach, Florida $323M AUM 17.08% 1-Year Est. Return

Barclays's BTAL Position: Q3 2026 in Review

Barclays opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2026: 1,797 shares worth $21.6K. The stake represents ﹤0.01% of the portfolio and ranks #4731 among its holdings.

42 funds tracked by Wall St. Rank hold BTAL as of Q3 2026.

  • Barclays held 1,797 shares of AGF US Market Neutral Anti-Beta Fund worth $21.6K as of Q3 2026.
  • AGF US Market Neutral Anti-Beta Fund was a new Barclays position in Q3 2026.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4731 holding.
  • 42 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.